Hims & Hers Health, Inc. (NYSE: HIMS) Stock Competitors & Peer Comparison
See HIMS's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HIMS and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HIMS | $27.80 | -0.09% | 6.2B | -43.30 | -$0.64 | N/A |
| HCA | $401.46 | -1.89% | 87.7B | 13.98 | $28.96 | +0.74% |
| THC | $260.11 | -1.28% | 21.3B | 15.37 | $17.24 | N/A |
| FMS | $22.51 | +0.16% | 12.2B | 8.52 | $2.66 | +3.81% |
| EHC | $121.08 | -1.24% | 12.1B | 20.85 | $5.84 | +0.62% |
| DVA | $181.48 | -0.10% | 11.8B | 14.37 | $12.80 | N/A |
| UHS | $171.12 | +1.13% | 10.3B | 7.53 | $22.54 | +0.47% |
| ENSG | $171.56 | -0.31% | 10B | 24.75 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| CHE | $521.66 | -0.53% | 6.8B | 24.06 | $21.61 | +0.48% |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
HIMS vs HCA Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, HCA has a market cap of 87.7B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while HCA trades at $401.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas HCA's P/E ratio is 13.98. In terms of profitability, HIMS's ROE is -0.30%, compared to HCA's ROE of -1.13%. Regarding short-term risk, HIMS is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
HIMS vs THC Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, THC has a market cap of 21.3B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while THC trades at $260.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas THC's P/E ratio is 15.37. In terms of profitability, HIMS's ROE is -0.30%, compared to THC's ROE of +0.51%. Regarding short-term risk, HIMS is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
HIMS vs FMS Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, FMS has a market cap of 12.2B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while FMS trades at $22.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas FMS's P/E ratio is 8.52. In terms of profitability, HIMS's ROE is -0.30%, compared to FMS's ROE of +0.07%. Regarding short-term risk, HIMS is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
HIMS vs EHC Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while EHC trades at $121.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas EHC's P/E ratio is 20.85. In terms of profitability, HIMS's ROE is -0.30%, compared to EHC's ROE of +0.25%. Regarding short-term risk, HIMS is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
HIMS vs DVA Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, DVA has a market cap of 11.8B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while DVA trades at $181.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas DVA's P/E ratio is 14.37. In terms of profitability, HIMS's ROE is -0.30%, compared to DVA's ROE of -1.24%. Regarding short-term risk, HIMS is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
HIMS vs UHS Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while UHS trades at $171.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas UHS's P/E ratio is 7.53. In terms of profitability, HIMS's ROE is -0.30%, compared to UHS's ROE of +0.21%. Regarding short-term risk, HIMS is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
HIMS vs ENSG Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while ENSG trades at $171.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas ENSG's P/E ratio is 24.75. In terms of profitability, HIMS's ROE is -0.30%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, HIMS is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
HIMS vs OSH Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas OSH's P/E ratio is -17.65. In terms of profitability, HIMS's ROE is -0.30%, compared to OSH's ROE of +4.64%. Regarding short-term risk, HIMS is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
HIMS vs CHE Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while CHE trades at $521.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas CHE's P/E ratio is 24.06. In terms of profitability, HIMS's ROE is -0.30%, compared to CHE's ROE of +0.29%. Regarding short-term risk, HIMS is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check CHE's competition here
PACS Group, Inc. (NYSE: PACS)
HIMS vs PACS Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, PACS has a market cap of 6.7B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while PACS trades at $43.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas PACS's P/E ratio is 22.49. In terms of profitability, HIMS's ROE is -0.30%, compared to PACS's ROE of +0.27%. Regarding short-term risk, HIMS is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check PACS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
HIMS vs LHCG Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas LHCG's P/E ratio is 82.83. In terms of profitability, HIMS's ROE is -0.30%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, HIMS is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
HIMS vs LFST Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while LFST trades at $12.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas LFST's P/E ratio is 95.88. In terms of profitability, HIMS's ROE is -0.30%, compared to LFST's ROE of +0.03%. Regarding short-term risk, HIMS is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
HIMS vs CON Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while CON trades at $34.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas CON's P/E ratio is 21.68. In terms of profitability, HIMS's ROE is -0.30%, compared to CON's ROE of +0.47%. Regarding short-term risk, HIMS is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
HIMS vs OPCH Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while OPCH trades at $23.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas OPCH's P/E ratio is 14.08. In terms of profitability, HIMS's ROE is -0.30%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, HIMS is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
HIMS vs NHC Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, NHC has a market cap of 3.4B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while NHC trades at $221.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas NHC's P/E ratio is 27.82. In terms of profitability, HIMS's ROE is -0.30%, compared to NHC's ROE of +0.13%. Regarding short-term risk, HIMS is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
HIMS vs AMED Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas AMED's P/E ratio is 39.30. In terms of profitability, HIMS's ROE is -0.30%, compared to AMED's ROE of +0.11%. Regarding short-term risk, HIMS is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
HIMS vs AVAH Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, AVAH has a market cap of 3B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while AVAH trades at $13.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas AVAH's P/E ratio is 19.97. In terms of profitability, HIMS's ROE is -0.30%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, HIMS is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
HIMS vs BKD Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, BKD has a market cap of 2.8B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while BKD trades at $12.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas BKD's P/E ratio is -20.29. In terms of profitability, HIMS's ROE is -0.30%, compared to BKD's ROE of +4.06%. Regarding short-term risk, HIMS is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
HIMS vs ACHC Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while ACHC trades at $27.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas ACHC's P/E ratio is 14.14. In terms of profitability, HIMS's ROE is -0.30%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, HIMS is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check ACHC's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
HIMS vs GRDN Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, GRDN has a market cap of 2.6B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while GRDN trades at $41.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas GRDN's P/E ratio is 35.76. In terms of profitability, HIMS's ROE is -0.30%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, HIMS is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
HIMS vs MD Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while MD trades at $26.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas MD's P/E ratio is 12.07. In terms of profitability, HIMS's ROE is -0.30%, compared to MD's ROE of +0.20%. Regarding short-term risk, HIMS is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
HIMS vs ADUS Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while ADUS trades at $119.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas ADUS's P/E ratio is 17.78. In terms of profitability, HIMS's ROE is -0.30%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, HIMS is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
HIMS vs SEM Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas SEM's P/E ratio is 15.43. In terms of profitability, HIMS's ROE is -0.30%, compared to SEM's ROE of +0.08%. Regarding short-term risk, HIMS is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
HIMS vs ASTH Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while ASTH trades at $37.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas ASTH's P/E ratio is 46.35. In terms of profitability, HIMS's ROE is -0.30%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, HIMS is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
HIMS vs SGRY Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while SGRY trades at $14.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas SGRY's P/E ratio is 36.56. In terms of profitability, HIMS's ROE is -0.30%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, HIMS is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
HIMS vs AMEH Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas AMEH's P/E ratio is 39.25. In terms of profitability, HIMS's ROE is -0.30%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, HIMS is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check AMEH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
HIMS vs SNDA Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, SNDA has a market cap of 1.8B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while SNDA trades at $39.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas SNDA's P/E ratio is -6.09. In terms of profitability, HIMS's ROE is -0.30%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, HIMS is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check SNDA's competition here
Ardent Health Inc. (NYSE: ARDT)
HIMS vs ARDT Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while ARDT trades at $10.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas ARDT's P/E ratio is 8.80. In terms of profitability, HIMS's ROE is -0.30%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, HIMS is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
HIMS vs HCSG Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while HCSG trades at $21.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas HCSG's P/E ratio is 17.46. In terms of profitability, HIMS's ROE is -0.30%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, HIMS is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check HCSG's competition here
Agilon Health, Inc. (NYSE: AGL)
HIMS vs AGL Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while AGL trades at $90.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas AGL's P/E ratio is -5.74. In terms of profitability, HIMS's ROE is -0.30%, compared to AGL's ROE of -1.19%. Regarding short-term risk, HIMS is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
HIMS vs INNV Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while INNV trades at $10.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas INNV's P/E ratio is -119.44. In terms of profitability, HIMS's ROE is -0.30%, compared to INNV's ROE of -0.09%. Regarding short-term risk, HIMS is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check INNV's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
HIMS vs NUTX Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while NUTX trades at $191.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas NUTX's P/E ratio is 7.65. In terms of profitability, HIMS's ROE is -0.30%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, HIMS is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check NUTX's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
HIMS vs PNTG Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while PNTG trades at $39.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas PNTG's P/E ratio is 28.79. In terms of profitability, HIMS's ROE is -0.30%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, HIMS is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
HIMS vs AMN Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while AMN trades at $33.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas AMN's P/E ratio is 11.23. In terms of profitability, HIMS's ROE is -0.30%, compared to AMN's ROE of +0.15%. Regarding short-term risk, HIMS is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
HIMS vs BKDT Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas BKDT's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, HIMS is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
HIMS vs USPH Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while USPH trades at $79.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas USPH's P/E ratio is 31.24. In terms of profitability, HIMS's ROE is -0.30%, compared to USPH's ROE of -0.01%. Regarding short-term risk, HIMS is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
HIMS vs TALK Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas TALK's P/E ratio is 774.34. In terms of profitability, HIMS's ROE is -0.30%, compared to TALK's ROE of +0.00%. Regarding short-term risk, HIMS is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
HIMS vs GMRS Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, GMRS has a market cap of 727M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while GMRS trades at $13.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas GMRS's P/E ratio is 5.98. In terms of profitability, HIMS's ROE is -0.30%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, HIMS is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
HIMS vs EHAB Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas EHAB's P/E ratio is -197.14. In terms of profitability, HIMS's ROE is -0.30%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, HIMS is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
HIMS vs STLN Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, STLN has a market cap of 592.9M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while STLN trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas STLN's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to STLN's ROE of +2.10%. Regarding short-term risk, HIMS is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
HIMS vs TOI Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas TOI's P/E ratio is -14.25. In terms of profitability, HIMS's ROE is -0.30%, compared to TOI's ROE of +2.10%. Regarding short-term risk, HIMS is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
HIMS vs SRTA Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, SRTA has a market cap of 460.3M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while SRTA trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas SRTA's P/E ratio is -25.08. In terms of profitability, HIMS's ROE is -0.30%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, HIMS is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
HIMS vs MCTA Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas MCTA's P/E ratio is 419.36. In terms of profitability, HIMS's ROE is -0.30%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, HIMS is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
HIMS vs CYH Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, CYH has a market cap of 407.5M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while CYH trades at $2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas CYH's P/E ratio is 3.96. In terms of profitability, HIMS's ROE is -0.30%, compared to CYH's ROE of +0.21%. Regarding short-term risk, HIMS is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
HIMS vs AUNA Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, AUNA has a market cap of 390.8M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while AUNA trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas AUNA's P/E ratio is 4.76. In terms of profitability, HIMS's ROE is -0.30%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, HIMS is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
HIMS vs VMD Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, VMD has a market cap of 345.8M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while VMD trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas VMD's P/E ratio is 25.22. In terms of profitability, HIMS's ROE is -0.30%, compared to VMD's ROE of +0.10%. Regarding short-term risk, HIMS is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
HIMS vs CSU Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas CSU's P/E ratio is 0.67. In terms of profitability, HIMS's ROE is -0.30%, compared to CSU's ROE of -0.33%. Regarding short-term risk, HIMS is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
HIMS vs AIRS Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, AIRS has a market cap of 197.2M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while AIRS trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas AIRS's P/E ratio is -93.17. In terms of profitability, HIMS's ROE is -0.30%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, HIMS is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
HIMS vs JYNT Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, JYNT has a market cap of 118.6M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while JYNT trades at $8.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas JYNT's P/E ratio is 83.20. In terms of profitability, HIMS's ROE is -0.30%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, HIMS is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
HIMS vs FVE Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas FVE's P/E ratio is -5.64. In terms of profitability, HIMS's ROE is -0.30%, compared to FVE's ROE of -0.15%. Regarding short-term risk, HIMS is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
HIMS vs KDLYW Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas KDLYW's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, HIMS is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
HIMS vs PARK Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, PARK has a market cap of 92.2M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while PARK trades at $20.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas PARK's P/E ratio is 27.61. In terms of profitability, HIMS's ROE is -0.30%, compared to PARK's ROE of -0.18%. Regarding short-term risk, HIMS is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
HIMS vs BTMD Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, BTMD has a market cap of 68.1M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while BTMD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas BTMD's P/E ratio is 14.05. In terms of profitability, HIMS's ROE is -0.30%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, HIMS is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
HIMS vs ALR Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas ALR's P/E ratio is -1.11. In terms of profitability, HIMS's ROE is -0.30%, compared to ALR's ROE of -0.15%. Regarding short-term risk, HIMS is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
HIMS vs DCGO Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, DCGO has a market cap of 39.8M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while DCGO trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas DCGO's P/E ratio is -0.22. In terms of profitability, HIMS's ROE is -0.30%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, HIMS is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
HIMS vs CCEL Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, CCEL has a market cap of 34.5M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while CCEL trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas CCEL's P/E ratio is -14.27. In terms of profitability, HIMS's ROE is -0.30%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, HIMS is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
HIMS vs IMAC Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas IMAC's P/E ratio is -2.27. In terms of profitability, HIMS's ROE is -0.30%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, HIMS is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
HIMS vs PIII Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, PIII has a market cap of 30.6M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while PIII trades at $8.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas PIII's P/E ratio is -0.28. In terms of profitability, HIMS's ROE is -0.30%, compared to PIII's ROE of +1.61%. Regarding short-term risk, HIMS is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check PIII's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
HIMS vs EUDA Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, EUDA has a market cap of 25.2M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while EUDA trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas EUDA's P/E ratio is -25.45. In terms of profitability, HIMS's ROE is -0.30%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, HIMS is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check EUDA's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
HIMS vs PIIIW Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, PIIIW has a market cap of 24.5M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas PIIIW's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, HIMS is more volatile compared to PIIIW. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO-WT)
HIMS vs CANO-WT Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, HIMS is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
HIMS vs AIH Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas AIH's P/E ratio is -2.78. In terms of profitability, HIMS's ROE is -0.30%, compared to AIH's ROE of +1.16%. Regarding short-term risk, HIMS is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
HIMS vs CANO Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas CANO's P/E ratio is -0.01. In terms of profitability, HIMS's ROE is -0.30%, compared to CANO's ROE of -1.49%. Regarding short-term risk, HIMS is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
HIMS vs FPCG Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas FPCG's P/E ratio is 0.09. In terms of profitability, HIMS's ROE is -0.30%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, HIMS is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
HIMS vs FTRP Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas FTRP's P/E ratio is -1.22. In terms of profitability, HIMS's ROE is -0.30%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, HIMS is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
HIMS vs AMS Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while AMS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas AMS's P/E ratio is -5.66. In terms of profitability, HIMS's ROE is -0.30%, compared to AMS's ROE of -0.07%. Regarding short-term risk, HIMS is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
HIMS vs BMGL Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, BMGL has a market cap of 7.6M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while BMGL trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas BMGL's P/E ratio is -0.91. In terms of profitability, HIMS's ROE is -0.30%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, HIMS is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
HIMS vs AIDX Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, AIDX has a market cap of 7.2M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while AIDX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas AIDX's P/E ratio is -1.12. In terms of profitability, HIMS's ROE is -0.30%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, HIMS is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
HIMS vs MODV Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas MODV's P/E ratio is -0.06. In terms of profitability, HIMS's ROE is -0.30%, compared to MODV's ROE of +1.36%. Regarding short-term risk, HIMS is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
HIMS vs GBNH Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas GBNH's P/E ratio is -0.06. In terms of profitability, HIMS's ROE is -0.30%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, HIMS is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check GBNH's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
HIMS vs STLNW Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, STLNW has a market cap of 5.3M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas STLNW's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, HIMS is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check STLNW's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
HIMS vs RHE-PA Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, HIMS's ROE is -0.30%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, HIMS is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
HIMS vs RHE Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas RHE's P/E ratio is -1.79. In terms of profitability, HIMS's ROE is -0.30%, compared to RHE's ROE of -1.31%. Regarding short-term risk, HIMS is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
HIMS vs TOIIW Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, HIMS's ROE is -0.30%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, HIMS is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
HIMS vs IMACW Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas IMACW's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, HIMS is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
HIMS vs EDVA Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, EDVA has a market cap of 1.7M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while EDVA trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas EDVA's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to EDVA's ROE of N/A. Regarding short-term risk, HIMS is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
HIMS vs EUDAW Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, HIMS's ROE is -0.30%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, HIMS is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
HIMS vs CCM Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, CCM has a market cap of 681.5K. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while CCM trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas CCM's P/E ratio is -0.31. In terms of profitability, HIMS's ROE is -0.30%, compared to CCM's ROE of +0.06%. Regarding short-term risk, HIMS is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
HIMS vs NIVF Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while NIVF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas NIVF's P/E ratio is 0.56. In terms of profitability, HIMS's ROE is -0.30%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, HIMS is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
HIMS vs NIVFW Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, NIVFW has a market cap of 45.7K. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, HIMS's ROE is -0.30%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, HIMS is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
HIMS vs MNDR Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, MNDR has a market cap of 34.9K. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while MNDR trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas MNDR's P/E ratio is -0.04. In terms of profitability, HIMS's ROE is -0.30%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, HIMS is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
HIMS vs TALKW Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas TALKW's P/E ratio is 0.00. In terms of profitability, HIMS's ROE is -0.30%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, HIMS is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check TALKW's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
HIMS vs SLHG Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas SLHG's P/E ratio is -1.48. In terms of profitability, HIMS's ROE is -0.30%, compared to SLHG's ROE of N/A. Regarding short-term risk, HIMS is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check SLHG's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
HIMS vs SLHGP Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, HIMS's ROE is -0.30%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, HIMS is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check SLHGP's competition here
Almost Family Inc. (NASDAQ: AFAM)
HIMS vs AFAM Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas AFAM's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, HIMS is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
HIMS vs TLMD Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas TLMD's P/E ratio is -1.60. In terms of profitability, HIMS's ROE is -0.30%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, HIMS is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check TLMD's competition here
Hanger, Inc. (NYSE: HNGR)
HIMS vs HNGR Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas HNGR's P/E ratio is 19.71. In terms of profitability, HIMS's ROE is -0.30%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, HIMS is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check HNGR's competition here
New Frontier Health Corporation (NYSE: NFH)
HIMS vs NFH Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, NFH has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas NFH's P/E ratio is -19.75. In terms of profitability, HIMS's ROE is -0.30%, compared to NFH's ROE of -0.06%. Regarding short-term risk, HIMS is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check NFH's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
HIMS vs DVCR Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas DVCR's P/E ratio is 28.34. In terms of profitability, HIMS's ROE is -0.30%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, HIMS is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check DVCR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
HIMS vs ATIP-WT Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, HIMS is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check ATIP-WT's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
HIMS vs TLMDW Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas TLMDW's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, HIMS is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check TLMDW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
HIMS vs TVTY Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas TVTY's P/E ratio is 19.06. In terms of profitability, HIMS's ROE is -0.30%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, HIMS is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check TVTY's competition here
DocGo Inc. (NASDAQ: DCGOW)
HIMS vs DCGOW Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas DCGOW's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.30%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, HIMS is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check DCGOW's competition here
Kindred Healthcare, Inc. (NYSE: KND)
HIMS vs KND Comparison September 2026
Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIMS stands at 6.2B. In comparison, KND has a market cap of 0. Regarding current trading prices, HIMS is priced at $27.80 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIMS currently has a P/E ratio of -43.30, whereas KND's P/E ratio is -1.14. In terms of profitability, HIMS's ROE is -0.30%, compared to KND's ROE of -0.53%. Regarding short-term risk, HIMS is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check KND's competition here